Trial Profile
Clinical Pharmacology Study of CS-3150 Drug-drug interaction study between CS-3150 and amlodipine in healthy Japanese subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Esaxerenone (Primary) ; Amlodipine
- Indications Diabetic neuropathies; Essential hypertension; Hyperaldosteronism; Hypertension
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 23 Mar 2017 Status changed from not yet recruiting to completed.
- 28 Sep 2016 New trial record